Timber Hill’s iShares Biotechnology ETF IBB Stock Holding History

Timber Hill’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-38,427	Closed	-$4.1M	–	158
2018 Q1	$4.1M	Buy	+38,427	New	+$4.26M	0.63%	30
2017 Q4	–	Sell	-8,169	Closed	-$908K	–	695
2017 Q3	$908K	Sell	8,169 -14,928	-65%	-$1.6M	0.08%	211
2017 Q2	$2.39M	Sell	23,097 -18,159	-44%	-$1.79M	0.09%	181
2017 Q1	$4.03M	Sell	41,256 -18,528	-31%	-$1.77M	0.03%	430
2016 Q4	$5.29M	Sell	59,784 -54,522	-48%	-$4.96M	0.02%	512
2016 Q3	$11M	Buy	114,306 +9,156	+9%	+$871K	0.05%	293
2016 Q2	$9.02M	Sell	105,150 -188,877	-64%	-$16.9M	0.04%	356
2016 Q1	$25.6M	Buy	294,027 +112,683	+62%	+$10.1M	0.12%	138
2015 Q4	$20.5M	Buy	181,344 +29,490	+19%	+$3.2M	0.1%	152
2015 Q3	$15.4M	Buy	151,854 +54,399	+56%	+$6.52M	0.06%	245
2015 Q2	$12M	Buy	97,455 +2,730	+3%	+$327K	0.05%	305
2015 Q1	$10.8M	Buy	94,725 +11,484	+14%	+$1.27M	0.05%	320
2014 Q4	$8.42M	Sell	83,241 -111,084	-57%	-$10.8M	0.03%	394
2014 Q3	$17.7M	Buy	194,325 +181,605	+1,428%	+$15.9M	0.07%	209
2014 Q2	$1.09M	Buy	+12,720	New	+$1M	﹤0.01%	1606
2014 Q1	–	Sell	-63,843	Closed	-$4.83M	–	2820
2013 Q4	$4.83M	Buy	63,843 +33,429	+110%	+$2.37M	0.02%	791
2013 Q3	$2.13M	Sell	30,414 -128,562	-81%	-$8.42M	0.01%	1416
2013 Q2	$9.21M	Buy	+158,976	New	+$9.19M	0.03%	479

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Timber Hill's IBB Position: Q2 2018 in Review

Timber Hill sold out of iShares Biotechnology ETF (IBB) in Q2 2018, closing a stake of 38,427 shares — an estimated $4.1M sold.

Timber Hill first reported a position in IBB in Q2 2013 and held it in 18 quarters. The position peaked at $25.6M in Q1 2016. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

Timber Hill reported no remaining iShares Biotechnology ETF position as of Q2 2018 after selling out during the quarter.
Timber Hill sold 38,427 iShares Biotechnology ETF shares in Q2 2018, an estimated $4.1M.
Timber Hill first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 18 quarters.
Timber Hill's iShares Biotechnology ETF position peaked at $25.6M in Q1 2016.
609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.